Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Successful Sparkle Power Programme Testing

17 Sep 2025 07:00

RNS Number : 5968Z
Quadrise PLC
17 September 2025
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

17 September 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Successful completion of Sparkle Power testing programme

 

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, is pleased to announce the successful completion of proof-of-concept and emissions testing programmes for its MSAR® and bioMSAR™ fuels at the Sparkle Power SA ("Sparkle") plant in El Giral, Panama.

 

These trials mark the first successful application of MSAR® and bioMSAR™ on Everllence (formerly MAN Energy Solutions) 4-stroke engines, expanding the commercial potential of these fuels across additional engine types in energy-intensive sectors seeking cost-effective decarbonisation solutions.

 

Testing on MSAR® and bioMSAR™ fuels was conducted over a 24 hour period on an Everllence 18V32/40 8MW engine. A subsequent shorter run was completed on a Everllence 9L28/32 4MW engine. The trials were conducted by experts from Quadrise and Sparkle, and supported by independent specialists in external engine performance, emissions and fuel testing.

 

The key success criteria of the main trial were met as follows:

 

· Engine efficiency was improved, consistent with results on Wärtsilä diesel engines.

· NOx emissions were reduced by 25% with bioMSAR and 32% with MSAR®.

· Particulate matter emissions were reduced by 20% using both fuels.

 

The Sparkle trials validated the expected performance of MSAR® and bioMSAR™ for commercial deployment and confirmed the fuel injection system modifications required to achieve maximum load. The parties are now jointly planning the next steps towards confirming commercial supply arrangements for Sparkle and fuel permitting in Panama.

Jason Miles, Chief Technology Officer of Quadrise, commented:

"The successful trials with Sparkle represent a significant milestone for Quadrise, demonstrating the viability of MSAR® and bioMSAR™ on Everllence 4-stroke engines through a strong collaborative endeavour. With confirmed improvements in engine efficiency and emissions, we look forward to advancing discussions with Sparkle and a regional supply partner to establish a commercial supply facility serving the power and marine sectors across Central America."

Jose Castillo, General Manager of Sparkle, commented:

 

"We are delighted to have completed the Everllence engine test of MSAR® and bioMSAR™ at our power plant. The Quadrise test has confirmed the fuels are viable replacements for heavy fuel oil at our facility.

Sparkle Power is committed to becoming more fuel efficient and conserving the environment by reducing emissions in accordance with the government's policies for environmental conservation in Panama. The test has confirmed that MSAR® and bioMSAR™ fuels can achieve the necessary criteria for commercial implementation in the country."

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Ruairi Millar

 

+44 (0) 20 7920 3150

 

 BLUE Communications Limited (Marine & Trade PR)

 Rhys Thomas

 Sam Deacon

 

 

 

+44 (0)7595 227750

+44 (0)7527 558846

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFTASIRLIE
Date   Source Headline
6th May 201011:53 amRNSHolding(s) in Company
4th May 201010:48 amRNSNotice of Results
28th Apr 20109:04 amRNSBarclaycard Partnership at Wembley Arena
20th Apr 201010:41 amRNSHolding(s) in Company
13th Apr 201012:46 pmRNSDirector/PDMR Shareholding
12th Apr 20104:10 pmRNSHolding(s) in Company
31st Mar 20107:00 amRNSPre-close statement
26th Mar 201011:24 amRNSDirector/PDMR Shareholding
22nd Mar 20109:22 amRNSFund Management Presentation
26th Feb 20102:39 pmRNSDirector/PDMR Shareholding
18th Feb 20107:00 amRNSDirectorate Change
16th Feb 201012:43 pmRNSDirector/PDMR Shareholding
21st Jan 20102:51 pmRNSDirector/PDMR Shareholding
21st Jan 20107:01 amRNSInterim Management Statement
21st Jan 20107:00 amRNSDirectorate Change
29th Dec 20095:06 pmRNSHolding(s) in Company
22nd Dec 20093:21 pmRNSHolding(s) in Company
15th Dec 200911:07 amRNSHolding(s) in Company
15th Dec 200910:59 amRNSDirector/PDMR Shareholding
14th Dec 20093:29 pmRNSDirector/PDMR Shareholding
11th Dec 20093:18 pmRNSHolding(s) in Company
11th Dec 20093:10 pmRNSDirector/PDMR Shareholding
10th Dec 20091:48 pmPRNDisclosure of Short Position
10th Dec 20091:48 pmPRNDisclosure of Short Position
10th Dec 20091:17 pmRNSDirector/PDMR Shareholding
10th Dec 20099:29 amRNSTotal Voting Rights
10th Dec 20099:15 amRNSHolding(s) in Company
10th Dec 20099:13 amRNSRESULT OF RUMP PLACING
10th Dec 20097:00 amRNSRESULT OF RIGHTS ISSUE
9th Dec 20093:54 pmPRNDisclosure of Short Position - TR3
9th Dec 20093:20 pmRNSDisclosure of Short Position
8th Dec 20099:38 amRNSDirector/PDMR Shareholding
7th Dec 20092:32 pmRNSHolding(s) in Company
7th Dec 20092:18 pmPRNDisclosure of Short Position - TR3
7th Dec 20092:14 pmBUSDisclosure of Short Position
7th Dec 200912:47 pmPRNDisclosure of Short Position - TR3
4th Dec 20095:46 pmRNSDisclosure of Short Position
4th Dec 20092:29 pmBUSDisclosure of Short Position
4th Dec 200910:11 amPRNShort Selling Disclosure
4th Dec 200910:10 amPRNShort Selling Disclosure
3rd Dec 20094:34 pmPRNDisclosure of Short Position - TR3
3rd Dec 200910:00 amPRNShort Selling Disclosure
3rd Dec 20099:55 amPRNShort Selling Disclosure
2nd Dec 20094:03 pmRNSHolding(s) in Company
2nd Dec 20091:55 pmBUSDisclosure of Short Position
2nd Dec 200912:13 pmBUSDisclosure of Short Position
1st Dec 200912:45 pmRNSDisclosure of Short Position
26th Nov 20093:29 pmRNSDirector/PDMR Shareholding
26th Nov 20091:06 pmBUSDisclosure of Short Position
26th Nov 20091:04 pmBUSDisclosure of Short Position

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.